butorphanol + tropisetron

The combination of butorphanol and tropisetron is a therapeutic regimen primarily used in the management of postoperative pain and the prevention of opioid-induced side effects. Butorphanol is a mixed opioid agonist-antagonist that acts as a potent agonist at the kappa-opioid receptor and a partial agonist or antagonist at the mu-opioid receptor, providing effective analgesia with a lower incidence of respiratory depression compared to pure mu-agonists. Tropisetron is a selective 5-HT3 receptor antagonist used to mitigate nausea and vomiting, common adverse reactions associated with opioid administration and surgical procedures. This combination is frequently administered via patient-controlled analgesia (PCA) pumps. Clinical research, including studies conducted at institutions such as Qingdao Women and Children's Hospital, has focused on optimizing this combination to improve patient recovery outcomes by balancing pain relief with the reduction of postoperative nausea, vomiting, and pruritus.

Other names

butorphanol tartrate + tropisetron hydrochloride